Researchers at the Biodesign Institute at Arizona State University have found a way to get molecular binding agents to act like antibodies and, in the process, optimize the binding agents affinity for targeted proteins. The development revealed important nuances of protein function and could lead to better diagnosis and treatment for a range of diseases. The researchers published their findings Aug. 16 in the journal ChemBioChem.

NeuroLogica has received CE Mark approval for its portable inSPira HD SPECT camera.

Carestream Health has launched an enhanced version of Kodak MIN-R 2000 film for mammography, which is being released globally.

The National Human Genome Research Institute (NHGRI) awarded the Mayo Clinic a $3 million, four-year grant to help bring genomic-based tools into cardiology clinical practice. The grant allows researchers at the Rochester, Minn.-based provider to continue collaborating with partners in the Electronic Medical Records and Genomics Network (eMERGE), a seven-site project that couples EMRs with DNA repositories.

With the future of the U.S. healthcare payment system still up in the air, hospitals struggle to find ways to perform care at the most effective price. While some have chosen integration as a means to stay afloat, others have turned to hospital IT to help meet meaningful use criteria and gain reimbursements for high quality care. What are the best tactics hospitals can take to streamline care at a more cost-effective price tag?

Devicor Medical Products, a private equity firm and a GTCR company, has completed its previously annouced acquisition of the neoprobe gamma detection system products and related assets from Neoprobe of Dublin, Ohio.

To help hospitals and imaging centers build new or expand upon existing education and patient care initiatives, the Association for Medical Imaging Management (AHRA) announces the fourth year of its Putting Patients First Program.

U-Systems has received Health Canada approval to market and sell its somov Automated Breast Ultrasound System (ABUS) as an adjunct to mammography for screening asymptomatic women for breast cancer in Canada.